ReviewFrontiers in medicine2026
Ventilator-induced lung injury: from mechanisms to integrated clinical management.
Review in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Currently, there are no definitive diagnostic criteria for Ventilator-induced lung injury (VILI), and the mechanisms underlying its development and progression remain incompletely understood. These mechanisms involve a complex interplay of factors, including barotrauma, volutrauma, atelectrauma, and biotrauma. Central to these issues are excessive lung tissue distension, the cyclic opening and closing of alveoli, and the activation and release of inflammatory mediators. Moreover, emerging concepts such as patient self-inflicted lung injury (P-SILI) and mechanical power have further expanded our understanding of VILI. These concepts underscore the critical roles of respiratory drive and mechanical energy transfer in the injury process. An in-depth analysis of the mechanisms underlying VILI suggests that its clinical prevention requires a dynamic and phase-specific strategy throughout the entire mechanical ventilation process. During the controlled ventilation phase, the primary focus should be on implementing a lung-protective ventilation strategy, which includes the use of low tidal volume and driving pressure, individualized positive end-expiratory pressure titration, prone positioning and extracorporeal life support to minimize pulmonary stress and strain. In the transition phase, attention should shift to modulating respiratory drive and ensuring optimal patient-ventilator synchrony to prevent P-SILI. Finally, during the weaning phase, emphasis should be placed on systematic assessment and spontaneous breathing trials to achieve safe liberation from mechanical ventilation. Here, we summarize the main mechanisms underlying VILI and outline prevention strategies to enhance understanding and management of this complication among clinical healthcare providers, ultimately to improve patient clinical outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.